Clinical Trial Update: Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dronabinol with standard ondansetron therapy to prevent delayed-onset chemotherapy-induced nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Dronabinol (dronabinol)
• Ondansetron (ondansetron)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Chemotherapy Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED